Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin

Published:2017-01-30 Issue:3 Volume:37 Page:1815-1825
ISSN:1021-335X
Container-title:Oncology Reports
language:en
Short-container-title:

Author:

Yuan Zeting,Shi Xiaojing,Qiu Yanyan,Jia Tingting,Yuan Xia,Zou Yu,Liu Cheng,Yu Hui,Yuan Yuxia,He Xue,Xu Ke,Yin Peihao

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combinational Antitumor Strategies Based on the Active Ingredients of Toad Skin and Toad Venom;Drug Design, Development and Therapy;2024-08

2. Development and evaluation of hyaluronic acid conjugated tacrolimus-loaded nanostructured lipid carriers using moringa oleifera seed oil as liquid lipid;Journal of Drug Delivery Science and Technology;2024-05

3. Cytochrome P450 Mining for Bufadienolide Diversification;ACS Chemical Biology;2024-04-16

4. High-dose short-term osimertinib treatment is effective in patient-derived metastatic colorectal cancer organoids;BJC Reports;2024-04-03

5. m6A methylation pattern of SLC7A11 mediates the effects of cinobufagin on hepatocellular carcinoma cell proliferation and radioresistance;INT J RADIAT RES;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP